US HB7035 | 2021-2022 | 117th Congress
Status
Spectrum: Bipartisan Bill
Status: Introduced on March 9 2022 - 25% progression, died in committee
Action: 2022-03-10 - Referred to the Subcommittee on Health.
Pending: House Subcommittee on Health Committee
Text: Latest bill text (Introduced) [PDF]
Status: Introduced on March 9 2022 - 25% progression, died in committee
Action: 2022-03-10 - Referred to the Subcommittee on Health.
Pending: House Subcommittee on Health Committee
Text: Latest bill text (Introduced) [PDF]
Summary
To amend the Federal Food, Drug, and Cosmetic Act to require prompt reports of marketing status by holders of approved applications for biological products, and for other purposes.
Title
Biologics Market Transparency Act of 2022
Sponsors
| Rep. Kathy Manning [D-NC] | Rep. Richard Hudson [R-NC] |
History
| Date | Chamber | Action |
|---|---|---|
| 2022-03-10 | House | Referred to the Subcommittee on Health. |
| 2022-03-09 | House | Referred to the House Committee on Energy and Commerce. |
| 2022-03-09 | House | Introduced in House |
Same As/Similar To
HB7667 (Related) 2022-06-09 - Received in the Senate.
SB4348 (Related) 2022-07-13 - Placed on Senate Legislative Calendar under General Orders. Calendar No. 444.
SB4302 (Related) 2022-05-25 - Read twice and referred to the Committee on Health, Education, Labor, and Pensions. (Sponsor introductory remarks on measure: CR S2709)
SB4348 (Related) 2022-07-13 - Placed on Senate Legislative Calendar under General Orders. Calendar No. 444.
SB4302 (Related) 2022-05-25 - Read twice and referred to the Committee on Health, Education, Labor, and Pensions. (Sponsor introductory remarks on measure: CR S2709)
Subjects
US Congress State Sources
| Type | Source |
|---|---|
| Summary | https://www.congress.gov/bill/117th-congress/house-bill/7035/all-info |
| Text | https://www.congress.gov/117/bills/hr7035/BILLS-117hr7035ih.pdf |
